|
|
|
|
| 专题 |
最后回覆 |
昵称 |
内容 |
| 联邦制药国际控股有限公司 |
2014-04-24T09:43 |
财经茄呢啡 |
联邦制药（3933）去年纯利大跌七成，仅赚4,800万银，但绩后飙四成皆因业绩似差实佳，撇除一次性项目，税后溢利增2.8倍至4.02亿元。高盛认为在胰岛素及新产品推动下，今年盈利将显着增长。以税后溢利计，现价PE22倍，药股来讲并唔贵，计埋增长潜力，以30倍PE计，可见7.4元。 |
|
|
|
|
We've noticed you're using an ad blocker
We spend millions of dollars each year so you can access, for FREE, the highest quality real-time quotes and charts. This is made possible only thanks to the advertising on our site.
To continue using 88iv.com, please allow this domain on your ad blocker.
We are thanksful for your decisive action.
This notice will be shown again every hour.
Close This Window